Remove Bioinformatics Remove Protein Expression Remove Protein Production Remove Virus
article thumbnail

Finding the right CDMO partner for cell line development

Drug Target Review

Together, these attributes provide a strong foundation for protein expression with enough adaptability to produce much of the commercial and therapeutic protein market. They’re prepared for complexity Successful expression of the gene of interest is not sufficient on its own for large-scale production.

article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

The luncheon presentations include: Nikki Machalek, Scientist II, KBI Biopharma, on: ‘Comprehensive size distribution analysis of adeno-associated virus fill-states’. Peter Herr Neubauer, PhD, Lab Head, Bioprocess Engineering, TU Berlin, on: “Automated model based optimisation of difficult-to-express protein processes in a robotic facility”.

article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Thereafter, there will be the following presentations: Georgios Skretas, PhD, Director, Institute for Bio-innovation, Biomedical Sciences Research Center “Alexander Fleming;” Founder & CEO, ResQ Biotech, on: ‘Development of specialised bacterial strains for high-level production of recombinant membrane proteins’.